Carl L. Gordon
DirectoratArriVent BioPharma· In proxies 2023–2024
Carl L. Gordon sits on 8 public boards.
Boards1
- Keros TherapeuticsChair · 3 yr on the boardIndependentCompensation (Chair)—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- ArriVent BioPharmaPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -21%
- Keros TherapeuticsPublic company · 3 yr
- Chair of the Board2023 – Present · 3 yrNo stock prices for these years
- Adicet Bio, Inc.Public company
- Director? – PresentNo stock prices for these years
- Compass Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Lomond Therapeutics Holdings, Inc.Public company
- Director? – PresentNo stock prices for these years
- MBX Biosciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Terns Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?